Physician profile
William C Martin
NPI 1811954779
$207,729.20
in general payments reported to CMS, 2019-2025
5 companies · $44K in 2025
The $44K reported for 2025 was more than what 98% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $37K · 2021: $30K · 2022: $42K · 2023: $31K · 2024: $23K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $61K · Consulting Fee: $27K · Travel and Lodging: $8,100 · Education: $1,200 · Food and Beverage: $461 · Gift: $318 · Entertainment: $48.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $61,375.00 |
| Consulting Fee | $26,579.69 |
| Travel and Lodging | $8,100.00 |
| Education | $1,200.00 |
| Food and Beverage | $461.14 |
| Gift | $318.35 |
| Entertainment | $48.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $205,380.14 | 2019-2025 | |
| Henry Schein, INC. | $1,829.69 | 2024 | |
| Meisinger USA, LLC | $318.35 | 2023 | Tf02, Ele01, Cosi1 |
| Geistlich Pharma, North America, INC. | $179.51 | 2024 | Geistlich Bio-Gide |
| Dentsply Sirona INC | $21.51 | 2024 | Astra Tech Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.